If you experience increased bowel frequency or looser stools whilst taking GLP-1 medication, several practical strategies can help manage these symptoms whilst allowing you to continue benefiting from treatment
Unfortunately, some patients still show limited response to DMARDs, which puts forward new requirements for special targets and novel therapies
When making referral decisions, your doctor may use the weighted 7-point checklist which has been recommended by NICE (National Institute for Health and Care Excellence) for routine use in UK general practice, as follows: All suspicious pigmented skin lesions that score 3 points or more using this check list should be referred urgently (within 2 weeks) to a dermatologist for professional clinical assessment
Start with a low dose to assess the impact and any adverse events
Your treatment begins with 2.5 mg injected once weekly for four weeks
How GLP-1 drugs work Agonists are substances that mimic the actions of certain chemicals in the bodyneurotransmitters or hormonesto produce a response upon binding to a specific receptor on a cell